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Adipose tissue is themain site of storage andmobilization of lipid. In a recent study published inNature, Arner
et al. (2011) report that high storage and low removal of adipose triglycerides promotes obesity, whereas low
storage and low removal favor the development of dyslipidemia in humans.Adipose tissue fat cells have the unique
capacity to accumulate large amounts of
energy-rich triglycerides in specialized
lipid droplets. Body fat mass is the result
of the balance between storage and re-
moval of fat cell triglycerides. When food
calories are supplied in excess, fat mass
increases, whereas in situations of energy
demand such as fasting, triglycerides
from adipose tissue are hydrolyzed into
fatty acids (lipolysis) with subsequent
fatty acid oxidation. In a study recently
published in Nature, Peter Arner, Kirsti
Spalding, and collaborators determined
the age of lipids in human subcutaneous
adipose tissue (Arner et al., 2011). The
method uses the temporary enrichment
of 14C in the atmosphere during above-
ground nuclear bomb tests between
1955 and 1963. After cessation of the
tests, 14C levels exponentially decreased
as 14CO2 was incorporated into organic
compounds during plant photosynthesis.
Because humans eat plants or animals
having eaten plants, the 14C concentra-
tion in the human body parallels that in
the atmosphere. The incorporation of
atmospheric 14C into adipose tissue lipid
was determined to estimate lipid age,
which reflects the irreversible removal of
lipids from fat stores in lipolysis followed
by fatty acid oxidation and/or ectopic
deposition in nonadipose tissues, e.g., in
skeletal muscle and liver. From lipid age
and total fat mass, the authors calculated
the net lipid storage, which represents the
amount of lipid stored in adipose tissue
each year and reflects fat incorporation
from exogenous sources (e.g., derived
from food) and endogenous synthesis
(e.g., de novo synthesis of fatty acidsfrom glucose) subtracted from the irre-
versible removal of lipids.
Mean adipocyte lipid age was 1.6
years. As mean fat cell age was previ-
ously shown to be 9.5 years, this implies
that during the life span of an adipocyte,
triglycerides are replaced six times on
average (Spalding et al., 2008). Spalding
and colleagues also found that lipid age
was inversely correlated with adipocyte
lipolysis stimulated by various mole-
cules, indicating that lipolysis is an
important determinant of lipid removal.
Although stimulated lipolysis rate corre-
lated with fat cell size (Reynisdottir
et al., 1997), lipid age was similar in fat
depots with small or large adipocytes.
This observation suggests an exchange
of fatty acids within adipose tissue
between adipocytes of different sizes
and metabolic capacities. Indeed, fatty
acid esterification is coupled to lipolysis
in fat cells (Bezaire et al., 2009). The
lack of variation in lipid age over the
years does not preclude short-term
changes in the dynamics of lipid turnover
such as the ‘‘last in, first out’’ replace-
ment of fatty acids in triglycerides (Ek-
stedt and Olivecrona, 1970) or selective
release of fatty acids according to
molecular structure (Raclot et al., 1997).
Given the documented difference in fat
metabolism according to gender (Blaak,
2001), it is also puzzling that no differ-
ence in lipid storage and removal was
observed between men and women,
again highlighting the tight long-term
control of adipose lipid turnover. The
nature of the genetic and epigenetic
mechanisms determining this control
remains elusive.Cell Metabolism 14,In pathological conditions, however,
disturbances in the dynamics of adipose
tissue lipids were observed (Arner et al.,
2011). Obesity was characterized by in-
creased lipid storage and decreased lipid
removal (Figure 1). In familial combined
hyperlipidemia (FCHL), a hereditary lipid
disorder predisposing to premature coro-
nary heart disease, both triglyceride
storage and lipid removal rates were low.
This defect in lipid storage induces a
routingof fatty acids to the liver,where fatty
acid overflow contributes to the mixed
dyslipidemia characteristic of this condi-
tion.Moreover, ectopic deposition of lipids
in liver and skeletal muscle may favor the
development of insulin resistance through
lipotoxic mechanisms (Samuel et al.,
2010). Indeed, lipodystrophic patients
that have a defect of triglyceride storage
in adipose tissue resulting in lipid accumu-
lation elsewhere in the body develop
severe insulin resistance. At the other end
of the spectrum, increased capacity to
store fat with low net mobilization leads to
expansion of fat mass and may also be
viewed as a way to do a safe deposit of
lipids into a harmless compartment.
According to the adipose tissue expand-
ability hypothesis, as long as an individual
has the capacity to store fat in adipose
tissue, there is no ectopic deposition of
lipids and resulting metabolic complica-
tions (Virtue and Vidal-Puig, 2008). In the
obese population, Spalding and col-
leagues found that lipid storage capacity
was correlated to body mass index, but
not to HOMA-IR, an index of insulin resis-
tance. Lipid age, on the other hand, was
correlated to HOMA-IR, but not to body
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Figure 1. Lipid Turnover in Adipose Tissue of Nonobese, Obese, and
Nonobese-with-FCHL Individuals
Increased lipid storage and decreased lipid removal favors the expansion of
fat mass in obesity. If the capacity of storage is exceeded, there is ectopic lipid
deposition in other organs, which favors metabolic complications leading to
diabetes and cardiovascular diseases. In familial combined hyperlipidemia
(FCHL), both triglyceride storage and lipid removal rates are low. FAs (fatty




nants of adipose lipid turn-
over, fat mass, and insulin
sensitivity.
Metabolic complications
are also related to the distri-
bution of fat in different anat-
omical locations. Prospective
studies have shown that an
excess of visceral fat is asso-
ciated with increased mor-
tality and risk for diabetes
and cardiovascular complica-
tions (Wajchenberg, 2000). It
will be of interest to compare
lipid storage and lipid age in
visceral and subcutaneous
fat and to determine whether
the putative differences be-
tween the two fat depots
vary according to fat mass.
Another intriguing observa-
tion is the fact that storage
and removal of adipose lipids
proved constant during adult-hood. This is also the case for fat cell
number and turnover rate (Spalding
et al., 2008). Therefore, in individuals
with early-onset obesity, the higher
number of adipocytes is set during child-
hood and adolescence. The metabolism
of adipocytes is also fixed during that
period, with increased capacity for
storing lipids and decreased capacity for
mobilizing lipids. Identification of the
genetic and environmental factors deter-
mining the number and metabolism of
fat cells may help in designing novel
therapeutic strategies to prevent the570 Cell Metabolism 14, November 2, 2011 ªdevelopment of obesity and related
complications.
The article by Arner et al. contains
seminal data on the dynamics of adipose
tissue lipid turnover. It reveals that
fatty acid metabolism in this tissue is
tightly controlled during adulthood and
identifies defects in this metabolism in
two common metabolic disorders, obe-
sity and FCHL. The study provides
a theoretical framework for future work
on lipid metabolism in the context of
impaired glucose metabolism and insulin
resistance.2011 Elsevier Inc.ACKNOWLEDGMENTS
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